These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7479466)

  • 1. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.
    Tormey WP; FitzGerald RJ
    Postgrad Med J; 1995 Sep; 71(839):542-5. PubMed ID: 7479466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.
    Carling RS; Degg TJ; Allen KR; Bax ND; Barth JH
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):577-82. PubMed ID: 12564839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing, treating and managing carcinoid tumours.
    Burgess A
    Nurs Times; 2005 Jul 19-25; 101(29):32-4. PubMed ID: 16052941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy.
    Shakir KM; Jasser MZ; Yoshihashi AK; Drake AJ; Eisold JF
    Mayo Clin Proc; 1996 Dec; 71(12):1145-9. PubMed ID: 8945484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulovillous adenoma of the duodenum: a new etiology for flushing and urinary 5-HIAA elevation.
    Betchen SA; Cirigliano M; Furth EE; Broussard D; Grippi M; Lichtenstein GR
    Dig Dis Sci; 1998 Jul; 43(7):1474-81. PubMed ID: 9690381
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
    Kema IP; de Vries EG; Schellings AM; Postmus PE; Muskiet FA
    Clin Chem; 1992 Apr; 38(4):534-40. PubMed ID: 1373675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
    Ruszniewski P; Ducreux M; Chayvialle JA; Blumberg J; Cloarec D; Michel H; Raymond JM; Dupas JL; Gouerou H; Jian R; Genestin E; Bernades P; Rougier P
    Gut; 1996 Aug; 39(2):279-83. PubMed ID: 8977344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of 5-HT and 5-HIAA in the diagnosis of apudomas].
    Xu SH; Chen YF; Chen HC
    Zhonghua Nei Ke Za Zhi; 1990 Jul; 29(7):428-31, 446. PubMed ID: 1704304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of uniformity in the clinical approach to the interpretation of urinary catecholamines and their metabolites.
    Tormey WP; FitzGerald RJ
    Ir J Med Sci; 1995; 164(2):146-50. PubMed ID: 7607842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement.
    Adaway JE; Dobson R; Walsh J; Cuthbertson DJ; Monaghan PJ; Trainer PJ; Valle JW; Keevil BG
    Ann Clin Biochem; 2016 Sep; 53(Pt 5):554-60. PubMed ID: 26438520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.
    Zuetenhorst JM; Korse CM; Bonfrer JM; Peter E; Lamers CB; Taal BG
    Clin Chem; 2004 Sep; 50(9):1634-9. PubMed ID: 15247155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.
    van der Horst-Schrivers AN; Post WJ; Kema IP; Links TP; Willemse PH; Wymenga AN; de Vries EG
    Eur J Cancer; 2007 Dec; 43(18):2651-7. PubMed ID: 17825550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When is an indole not an indole?
    Martin JA; Brownbill K
    Clin Chem; 1998 Jan; 44(1):186. PubMed ID: 9550580
    [No Abstract]   [Full Text] [Related]  

  • 15. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.
    Joy T; Walsh G; Tokmakejian S; Van Uum SH
    Can J Gastroenterol; 2008 Jan; 22(1):49-53. PubMed ID: 18209781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simple test for pheochromocytoma as well as neuroblastoma and small intestine carcinoids. Analysis of 3-methoxy-4-hydroxymandelic acid, 3-methoxy-4-hydroxyphenylacetic acid and 5-hydroxy-indoleacetic acid in urine by chromatoelectrophoresis].
    Lachhein L; Schütz J
    Clin Chim Acta; 1967 Mar; 15(3):429-34. PubMed ID: 6034419
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of metastatic carcinoid tumour with recombinant interferon alfa.
    Joensuu H; Kumpulainen E; Gröhn P
    Eur J Cancer; 1992; 28A(10):1650-3. PubMed ID: 1382493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pitfalls in the diagnosis of carcinoids in patients treated with aminosalicylates].
    Dastych M; Dastych M; Zboril V; Senkyrík M; Starý K; Cáslavský J; Chmelík J
    Vnitr Lek; 2003 Mar; 49(3):200-4. PubMed ID: 12733495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
    Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
    Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.